(University of California - Los Angeles Health Sciences) A UCLA-led study has found that a treatment that uses a bacteria-like agent in combination with an immunotherapy drug could help some people with advanced melanoma, an aggressive form of skin cancer, live longer.
Original Article: Combination approach shows promise for beating advanced melanoma